Ocular Therapeutix, Inc

OCUL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001393434

SEC filings (opens in a new tab)

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Ocular Therapeutix, Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of OCUL: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	151	1	168	+18
Shares	137.4M	11.5M	140.0M	+14.1M (+11.2%)
Value	$939.8M	$78.8M	$1.22B	+$358.7M (+41.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Ocular Therapeutix, Inc at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to OCUL in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	11,354,164	$98.8M	0.00%
Assenagon Asset Management S.A.	2,825,756	$24.6M	0.05%
Artisan Partners Limited Partnership	1,056,092	$9.19M	0.01%
Woodline Partners LP	1,000,000	$8.70M	0.07%
Polar Asset Management Partners Inc.	492,900	$4.29M	0.10%
Pale Fire Capital SE	438,200	$3.81M	0.60%
PFM Health Sciences, LP	402,843	$3.50M	0.20%
Panagora Asset Management Inc	264,355	$2.30M	0.01%
Patient Square Capital LP	235,498	$2.05M	0.76%
Gsa Capital Partners LLP	126,681	$1.10M	0.08%
American Century Companies Inc	74,491	$648.1K	0.00%
Verition Fund Management LLC	62,501	$543.8K	0.00%
Intech Investment Management LLC	48,483	$421.8K	0.00%
SG Americas Securities, LLC	45,187	$393.0K	0.00%
Allianz Asset Management GmbH	43,800	$381.1K	0.00%
SEI Investments Co	23,246	$202.2K	0.00%
Sherbrooke Park Advisers LLC	22,649	$197.0K	0.05%
Mangrove Partners	21,416	$186.3K	0.02%
Creative Planning	20,947	$182.2K	0.00%
AQR Capital Management LLC	17,488	$152.1K	0.00%
Diversified Trust Co	12,239	$106.5K	0.00%
Scotia Capital Inc.	12,138	$105.6K	0.00%
AJOVista, LLC	11,123	$96.8K	0.41%
Credit Agricole S A	11,100	$96.6K	0.00%
Xponance, Inc.	10,269	$89.3K	0.00%
Acadian Asset Management LLC	8,142	$70.0K	0.00%
Capital Performance Advisors LLP	8,034	$69.9K	0.02%
Catalyst Funds Management Pty Ltd	5,600	$48.7K	0.01%
Golden State Equity Partners	3,250	$28.3K	0.00%
Versant Capital Management, Inc	230	$2.00K	0.00%
Sterling Capital Management LLC	158	$1.38K	0.00%
Bessemer Group Inc	160	$1.00K	0.00%
Russell Investments Group, Ltd.	68	$592	0.00%
GAMMA Investing LLC	38	$331	0.00%
Parallel Advisors, LLC	1	$9	0.00%

Sold out (17)

Institutions that held Ocular Therapeutix, Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of OCUL in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Tri Locum Partners LP	514,642	$3.52M
Artia Global Partners LP	500,000	$3.42M
Jump Financial, LLC	123,442	$844.3K
Alpine Global Management, LLC	41,165	$281.6K
ADAR1 Capital Management, LLC	32,900	$225.0K
Triumph Capital Management	30,761	$210.4K
EntryPoint Capital, LLC	20,597	$140.9K
HighTower Advisors, LLC	17,768	$121.0K
Daymark Wealth Partners, LLC	15,000	$102.6K
Palumbo Wealth Management LLC	12,667	$86.6K
Dark Forest Capital Management LP	12,383	$84.7K
Quantbot Technologies LP	10,834	$74.1K
Algert Global LLC	10,114	$69.2K
Inceptionr LLC	10,087	$69.0K
Atlas Capital Advisors LLC	5,000	$34.2K
Comerica Bank	234	$1.60K
The PNC Financial Services Group, Inc.	106	$725

Not filed for Q3 2024 yet (1)

Institutions that held Ocular Therapeutix, Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OCUL in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	11,520,326	$78.8M